Clinical Trial Update: Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal [Phase 4]

View source ↗

Summary

A Phase 4 trial compared fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent reversal of warfarin in patients with acute bleed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding in the Setting of Long-term Anticoagulation Therapy
• Hemorrhage

Drugs mentioned

• 4-factor Prothrombin Complex Concentrate (prothrombin complex concentrate, 4-factor)
• Vitamin K antagonists reversal

Snippet

Sponsor: HealthPartners Institute | Conditions: Acute Bleeding on Long-Term Anticoagulation Therapy, Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2023-07-11